[Federal Register Volume 80, Number 67 (Wednesday, April 8, 2015)]
[Notices]
[Page 18848]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-07997]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to (FOA) DP15-001, Natural Experiments of the 
Impact of Population-targeted Health Policies to Prevent Diabetes and 
its Complications.
    Time And Date: 11 a.m.-6 p.m., May 5-6, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters For Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Natural Experiments of the Impact of Population-targeted Health 
Policies to Prevent Diabetes and its Complications, DP15-001, initial 
review.''
    Contact Person For More Information: Brenda Colley Gilbert, Ph.D., 
M.S.P.H., Director, Extramural Research Program Operations and 
Services, CDC, 4770 Buford Highway NE., Mailstop F-80, Atlanta, Georgia 
30341, Telephone: (770) 488-6295, [email protected].
The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2015-07997 Filed 4-7-15; 8:45 am]
 BILLING CODE 4163-18-P